Highlights DexCom, Inc.

Equities

DXCM

US2521311074

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-23 pm EDT			5-day change	1st Jan Change
125.6 ^USD	-3.78%		-3.17%	+1.22%

Apr. 30	Glutality Powered by StrideMD Announces Integration with Dexcom to Enhance Remote Diabetes Care with CGM Technology	CI
Apr. 26	Wall Street: the worst week of 2024 is followed by the best	CF

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Glutality Powered by StrideMD Announces Integration with Dexcom to Enhance Remote Diabetes Care with CGM Technology	Apr. 30	CI
Wall Street: the worst week of 2024 is followed by the best	Apr. 26	CF
Dexcom's profit beats estimates on strong glucose monitor demand	Apr. 25	RE
DexCom, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
DexCom Q1 Non-GAAP Earnings, Revenue Rise; 2024 Revenue Guidance Gains; Shares Fall After Hours	Apr. 25	MT
Earnings Flash (DXCM) DEXCOM Posts Q1 EPS $0.32, vs. Street Est of $0.27	Apr. 25	MT
Earnings Flash (DXCM) DEXCOM Posts Q1 Revenue $921M, vs. Street Est of $910.9M	Apr. 25	MT
DexCom, Inc. Provides Earnings Guidance for the Year 2024	Apr. 25	CI
MD Revolution Partners with Dexcom to Integrate Continuous Glucose Monitoring Systems with Its Remote Care Management Platform	Apr. 10	CI
DexCom is still in the running	Mar. 07
DexCom Shares Rise After Prescription-Free Glucose Biosensor Wins FDA Clearance	Mar. 06	MT
US FDA clears use of first over-the-counter continuous glucose monitor	Mar. 05	RE
DexCom Says Prescription-Free Glucose Biosensor Wins FDA Clearance	Mar. 05	MT
US FDA clears use of first over-the-counter continuous glucose monitor	Mar. 05	RE
DexCom, Inc. Announces the FDA Clears Stelo by Dexcom ? the First Glucose Biosensor	Mar. 05	CI
DexCom, Inc. Showcases Leadership in AID and Power of Dexcom CGM in Type 2 Diabetes with New Data at ATTD	Mar. 05	CI
DexCom, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 08	CI
Dexcom beats profit estimates on strong demand for glucose monitors	Feb. 08	RE
Dexcom Q4 Earnings, Revenue Increase; Sets 2024 Outlook	Feb. 08	MT
DexCom Guides For FY 2024 Revenue of $4.15-$4.35 Billion, vs CIQ Analyst Consensus of $4.34 Billion	Feb. 08	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

DexCom is still in the running

March 07, 2024 at 04:49 am EST